The global market for PD-1 and PD-L1 Monoclonal Antibody was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

PD-1/PD-L1 monoclonal antibody is an anti-tumor drug developed for the mechanism of tumor cell escape from T cell attack. By blocking the interaction between PD-L1 and PD-1, the ability of T cells to attack tumors is restored. The immunotherapy developed based on this has a broad-spectrum effect in the field of tumor treatment, showing significant therapeutic effects in various tumor treatments such as lung cancer, kidney cancer, colon cancer, ovarian cancer, liver cancer, melanoma, etc. At present, the industry pattern of PD-1/PD-L1 monoclonal antibody in China is gradually shaping, and the development prospects are gradually stabilizing. The future product effectiveness, potential demand for indications, and the ability of sales teams will be the core competitiveness of PD-1/PD-L1 monoclonal antibody products.

Report Scope

This report aims to provide a comprehensive presentation of the global market for PD-1 and PD-L1 Monoclonal Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PD-1 and PD-L1 Monoclonal Antibody.

The PD-1 and PD-L1 Monoclonal Antibody market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global PD-1 and PD-L1 Monoclonal Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the PD-1 and PD-L1 Monoclonal Antibody manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of PD-1 and PD-L1 Monoclonal Antibody Market Report

Report Metric	Details
Report Name	PD-1 and PD-L1 Monoclonal Antibody Market
Segment by Type	PD-1 PD-L1
Segment by Application	Hospital Other Medical Institutions
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Merk, Bristol-Myers Squibb Company, Roche, Pfizer, AstraZeneca, Junshi Biosciences, Innovent, Hengrui, BeiGene, Alphamab Oncology, Cstone, Akeso, Henlius Biotech, Lepu Biopharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of PD-1 and PD-L1 Monoclonal Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of PD-1 and PD-L1 Monoclonal Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the PD-1 and PD-L1 Monoclonal Antibody Market report?

Ans: The main players in the PD-1 and PD-L1 Monoclonal Antibody Market are Merk, Bristol-Myers Squibb Company, Roche, Pfizer, AstraZeneca, Junshi Biosciences, Innovent, Hengrui, BeiGene, Alphamab Oncology, Cstone, Akeso, Henlius Biotech, Lepu Biopharma

What are the Application segmentation covered in the PD-1 and PD-L1 Monoclonal Antibody Market report?

Ans: The Applications covered in the PD-1 and PD-L1 Monoclonal Antibody Market report are Hospital, Other Medical Institutions

What are the Type segmentation covered in the PD-1 and PD-L1 Monoclonal Antibody Market report?

Ans: The Types covered in the PD-1 and PD-L1 Monoclonal Antibody Market report are PD-1, PD-L1

1 PD-1 and PD-L1 Monoclonal Antibody Market Overview

1.1 Product Definition

1.2 PD-1 and PD-L1 Monoclonal Antibody by Type

1.2.1 Global PD-1 and PD-L1 Monoclonal Antibody Market Value Comparison by Type (2024 VS 2031)

1.2.2 PD-1

1.2.3 PD-L1

1.3 PD-1 and PD-L1 Monoclonal Antibody by Application

1.3.1 Global PD-1 and PD-L1 Monoclonal Antibody Market Value by Application (2024 VS 2031)

1.3.2 Hospital

1.3.3 Other Medical Institutions

1.4 Global PD-1 and PD-L1 Monoclonal Antibody Market Size Estimates and Forecasts

1.4.1 Global PD-1 and PD-L1 Monoclonal Antibody Revenue 2020-2031

1.4.2 Global PD-1 and PD-L1 Monoclonal Antibody Sales 2020-2031

1.4.3 Global PD-1 and PD-L1 Monoclonal Antibody Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 PD-1 and PD-L1 Monoclonal Antibody Market Competition by Manufacturers

2.1 Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Manufacturers (2020-2025)

2.2 Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Manufacturers (2020-2025)

2.3 Global PD-1 and PD-L1 Monoclonal Antibody Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of PD-1 and PD-L1 Monoclonal Antibody, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of PD-1 and PD-L1 Monoclonal Antibody, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of PD-1 and PD-L1 Monoclonal Antibody, Product Type & Application

2.7 Global Key Manufacturers of PD-1 and PD-L1 Monoclonal Antibody, Date of Enter into This Industry

2.8 Global PD-1 and PD-L1 Monoclonal Antibody Market Competitive Situation and Trends

2.8.1 Global PD-1 and PD-L1 Monoclonal Antibody Market Concentration Rate

2.8.2 The Global 5 and 10 Largest PD-1 and PD-L1 Monoclonal Antibody Players Market Share by Revenue

2.8.3 Global PD-1 and PD-L1 Monoclonal Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global PD-1 and PD-L1 Monoclonal Antibody Market Scenario by Region

3.1 Global PD-1 and PD-L1 Monoclonal Antibody Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global PD-1 and PD-L1 Monoclonal Antibody Sales by Region: 2020-2031

3.2.1 Global PD-1 and PD-L1 Monoclonal Antibody Sales by Region: 2020-2025

3.2.2 Global PD-1 and PD-L1 Monoclonal Antibody Sales by Region: 2026-2031

3.3 Global PD-1 and PD-L1 Monoclonal Antibody Revenue by Region: 2020-2031

3.3.1 Global PD-1 and PD-L1 Monoclonal Antibody Revenue by Region: 2020-2025

3.3.2 Global PD-1 and PD-L1 Monoclonal Antibody Revenue by Region: 2026-2031

3.4 North America PD-1 and PD-L1 Monoclonal Antibody Market Facts & Figures by Country

3.4.1 North America PD-1 and PD-L1 Monoclonal Antibody Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2020-2031)

3.4.3 North America PD-1 and PD-L1 Monoclonal Antibody Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe PD-1 and PD-L1 Monoclonal Antibody Market Facts & Figures by Country

3.5.1 Europe PD-1 and PD-L1 Monoclonal Antibody Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2020-2031)

3.5.3 Europe PD-1 and PD-L1 Monoclonal Antibody Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific PD-1 and PD-L1 Monoclonal Antibody Market Facts & Figures by Region

3.6.1 Asia Pacific PD-1 and PD-L1 Monoclonal Antibody Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific PD-1 and PD-L1 Monoclonal Antibody Sales by Region (2020-2031)

3.6.3 Asia Pacific PD-1 and PD-L1 Monoclonal Antibody Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America PD-1 and PD-L1 Monoclonal Antibody Market Facts & Figures by Country

3.7.1 Latin America PD-1 and PD-L1 Monoclonal Antibody Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2020-2031)

3.7.3 Latin America PD-1 and PD-L1 Monoclonal Antibody Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa PD-1 and PD-L1 Monoclonal Antibody Market Facts & Figures by Country

3.8.1 Middle East and Africa PD-1 and PD-L1 Monoclonal Antibody Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2020-2031)

3.8.3 Middle East and Africa PD-1 and PD-L1 Monoclonal Antibody Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global PD-1 and PD-L1 Monoclonal Antibody Sales by Type (2020-2031)

4.1.1 Global PD-1 and PD-L1 Monoclonal Antibody Sales by Type (2020-2025)

4.1.2 Global PD-1 and PD-L1 Monoclonal Antibody Sales by Type (2026-2031)

4.1.3 Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Type (2020-2031)

4.2 Global PD-1 and PD-L1 Monoclonal Antibody Revenue by Type (2020-2031)

4.2.1 Global PD-1 and PD-L1 Monoclonal Antibody Revenue by Type (2020-2025)

4.2.2 Global PD-1 and PD-L1 Monoclonal Antibody Revenue by Type (2026-2031)

4.2.3 Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Type (2020-2031)

4.3 Global PD-1 and PD-L1 Monoclonal Antibody Price by Type (2020-2031)

5 Segment by Application

5.1 Global PD-1 and PD-L1 Monoclonal Antibody Sales by Application (2020-2031)

5.1.1 Global PD-1 and PD-L1 Monoclonal Antibody Sales by Application (2020-2025)

5.1.2 Global PD-1 and PD-L1 Monoclonal Antibody Sales by Application (2026-2031)

5.1.3 Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Application (2020-2031)

5.2 Global PD-1 and PD-L1 Monoclonal Antibody Revenue by Application (2020-2031)

5.2.1 Global PD-1 and PD-L1 Monoclonal Antibody Revenue by Application (2020-2025)

5.2.2 Global PD-1 and PD-L1 Monoclonal Antibody Revenue by Application (2026-2031)

5.2.3 Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Application (2020-2031)

5.3 Global PD-1 and PD-L1 Monoclonal Antibody Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Merk

6.1.1 Merk Company Information

6.1.2 Merk Description and Business Overview

6.1.3 Merk PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Merk PD-1 and PD-L1 Monoclonal Antibody Product Portfolio

6.1.5 Merk Recent Developments/Updates

6.2 Bristol-Myers Squibb Company

6.2.1 Bristol-Myers Squibb Company Company Information

6.2.2 Bristol-Myers Squibb Company Description and Business Overview

6.2.3 Bristol-Myers Squibb Company PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Bristol-Myers Squibb Company PD-1 and PD-L1 Monoclonal Antibody Product Portfolio

6.2.5 Bristol-Myers Squibb Company Recent Developments/Updates

6.3 Roche

6.3.1 Roche Company Information

6.3.2 Roche Description and Business Overview

6.3.3 Roche PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Roche PD-1 and PD-L1 Monoclonal Antibody Product Portfolio

6.3.5 Roche Recent Developments/Updates

6.4 Pfizer

6.4.1 Pfizer Company Information

6.4.2 Pfizer Description and Business Overview

6.4.3 Pfizer PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Pfizer PD-1 and PD-L1 Monoclonal Antibody Product Portfolio

6.4.5 Pfizer Recent Developments/Updates

6.5 AstraZeneca

6.5.1 AstraZeneca Company Information

6.5.2 AstraZeneca Description and Business Overview

6.5.3 AstraZeneca PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue and Gross Margin (2020-2025)

6.5.4 AstraZeneca PD-1 and PD-L1 Monoclonal Antibody Product Portfolio

6.5.5 AstraZeneca Recent Developments/Updates

6.6 Junshi Biosciences

6.6.1 Junshi Biosciences Company Information

6.6.2 Junshi Biosciences Description and Business Overview

6.6.3 Junshi Biosciences PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Junshi Biosciences PD-1 and PD-L1 Monoclonal Antibody Product Portfolio

6.6.5 Junshi Biosciences Recent Developments/Updates

6.7 Innovent

6.7.1 Innovent Company Information

6.7.2 Innovent Description and Business Overview

6.7.3 Innovent PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Innovent PD-1 and PD-L1 Monoclonal Antibody Product Portfolio

6.7.5 Innovent Recent Developments/Updates

6.8 Hengrui

6.8.1 Hengrui Company Information

6.8.2 Hengrui Description and Business Overview

6.8.3 Hengrui PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Hengrui PD-1 and PD-L1 Monoclonal Antibody Product Portfolio

6.8.5 Hengrui Recent Developments/Updates

6.9 BeiGene

6.9.1 BeiGene Company Information

6.9.2 BeiGene Description and Business Overview

6.9.3 BeiGene PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue and Gross Margin (2020-2025)

6.9.4 BeiGene PD-1 and PD-L1 Monoclonal Antibody Product Portfolio

6.9.5 BeiGene Recent Developments/Updates

6.10 Alphamab Oncology

6.10.1 Alphamab Oncology Company Information

6.10.2 Alphamab Oncology Description and Business Overview

6.10.3 Alphamab Oncology PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Alphamab Oncology PD-1 and PD-L1 Monoclonal Antibody Product Portfolio

6.10.5 Alphamab Oncology Recent Developments/Updates

6.11 Cstone

6.11.1 Cstone Company Information

6.11.2 Cstone Description and Business Overview

6.11.3 Cstone PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Cstone PD-1 and PD-L1 Monoclonal Antibody Product Portfolio

6.11.5 Cstone Recent Developments/Updates

6.12 Akeso

6.12.1 Akeso Company Information

6.12.2 Akeso Description and Business Overview

6.12.3 Akeso PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Akeso PD-1 and PD-L1 Monoclonal Antibody Product Portfolio

6.12.5 Akeso Recent Developments/Updates

6.13 Henlius Biotech

6.13.1 Henlius Biotech Company Information

6.13.2 Henlius Biotech Description and Business Overview

6.13.3 Henlius Biotech PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Henlius Biotech PD-1 and PD-L1 Monoclonal Antibody Product Portfolio

6.13.5 Henlius Biotech Recent Developments/Updates

6.14 Lepu Biopharma

6.14.1 Lepu Biopharma Company Information

6.14.2 Lepu Biopharma Description and Business Overview

6.14.3 Lepu Biopharma PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue and Gross Margin (2020-2025)

6.14.4 Lepu Biopharma PD-1 and PD-L1 Monoclonal Antibody Product Portfolio

6.14.5 Lepu Biopharma Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 PD-1 and PD-L1 Monoclonal Antibody Industry Chain Analysis

7.2 PD-1 and PD-L1 Monoclonal Antibody Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 PD-1 and PD-L1 Monoclonal Antibody Production Mode & Process Analysis

7.4 PD-1 and PD-L1 Monoclonal Antibody Sales and Marketing

7.4.1 PD-1 and PD-L1 Monoclonal Antibody Sales Channels

7.4.2 PD-1 and PD-L1 Monoclonal Antibody Distributors

7.5 PD-1 and PD-L1 Monoclonal Antibody Customer Analysis

8 PD-1 and PD-L1 Monoclonal Antibody Market Dynamics

8.1 PD-1 and PD-L1 Monoclonal Antibody Industry Trends

8.2 PD-1 and PD-L1 Monoclonal Antibody Market Drivers

8.3 PD-1 and PD-L1 Monoclonal Antibody Market Challenges

8.4 PD-1 and PD-L1 Monoclonal Antibody Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Merk

Bristol Myers Squibb Company

List of Tables

Table 1. Global PD-1 and PD-L1 Monoclonal Antibody Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global PD-1 and PD-L1 Monoclonal Antibody Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global PD-1 and PD-L1 Monoclonal Antibody Market Competitive Situation by Manufacturers in 2024

Table 4. Global PD-1 and PD-L1 Monoclonal Antibody Sales (Units) of Key Manufacturers (2020-2025)

Table 5. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Manufacturers (2020-2025)

Table 6. Global PD-1 and PD-L1 Monoclonal Antibody Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market PD-1 and PD-L1 Monoclonal Antibody Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of PD-1 and PD-L1 Monoclonal Antibody, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of PD-1 and PD-L1 Monoclonal Antibody, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of PD-1 and PD-L1 Monoclonal Antibody, Product Type & Application

Table 12. Global Key Manufacturers of PD-1 and PD-L1 Monoclonal Antibody, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global PD-1 and PD-L1 Monoclonal Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PD-1 and PD-L1 Monoclonal Antibody as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global PD-1 and PD-L1 Monoclonal Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global PD-1 and PD-L1 Monoclonal Antibody Sales by Region (2020-2025) & (Units)

Table 18. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Region (2020-2025)

Table 19. Global PD-1 and PD-L1 Monoclonal Antibody Sales by Region (2026-2031) & (Units)

Table 20. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Region (2026-2031)

Table 21. Global PD-1 and PD-L1 Monoclonal Antibody Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Region (2020-2025)

Table 23. Global PD-1 and PD-L1 Monoclonal Antibody Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Region (2026-2031)

Table 25. North America PD-1 and PD-L1 Monoclonal Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2020-2025) & (Units)

Table 27. North America PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2026-2031) & (Units)

Table 28. North America PD-1 and PD-L1 Monoclonal Antibody Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America PD-1 and PD-L1 Monoclonal Antibody Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe PD-1 and PD-L1 Monoclonal Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2020-2025) & (Units)

Table 32. Europe PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2026-2031) & (Units)

Table 33. Europe PD-1 and PD-L1 Monoclonal Antibody Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe PD-1 and PD-L1 Monoclonal Antibody Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific PD-1 and PD-L1 Monoclonal Antibody Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific PD-1 and PD-L1 Monoclonal Antibody Sales by Region (2020-2025) & (Units)

Table 37. Asia Pacific PD-1 and PD-L1 Monoclonal Antibody Sales by Region (2026-2031) & (Units)

Table 38. Asia Pacific PD-1 and PD-L1 Monoclonal Antibody Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific PD-1 and PD-L1 Monoclonal Antibody Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America PD-1 and PD-L1 Monoclonal Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2020-2025) & (Units)

Table 42. Latin America PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2026-2031) & (Units)

Table 43. Latin America PD-1 and PD-L1 Monoclonal Antibody Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America PD-1 and PD-L1 Monoclonal Antibody Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa PD-1 and PD-L1 Monoclonal Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2020-2025) & (Units)

Table 47. Middle East and Africa PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2026-2031) & (Units)

Table 48. Middle East and Africa PD-1 and PD-L1 Monoclonal Antibody Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa PD-1 and PD-L1 Monoclonal Antibody Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global PD-1 and PD-L1 Monoclonal Antibody Sales (Units) by Type (2020-2025)

Table 51. Global PD-1 and PD-L1 Monoclonal Antibody Sales (Units) by Type (2026-2031)

Table 52. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Type (2020-2025)

Table 53. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Type (2026-2031)

Table 54. Global PD-1 and PD-L1 Monoclonal Antibody Revenue (US$ Million) by Type (2020-2025)

Table 55. Global PD-1 and PD-L1 Monoclonal Antibody Revenue (US$ Million) by Type (2026-2031)

Table 56. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Type (2020-2025)

Table 57. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Type (2026-2031)

Table 58. Global PD-1 and PD-L1 Monoclonal Antibody Price (US$/Unit) by Type (2020-2025)

Table 59. Global PD-1 and PD-L1 Monoclonal Antibody Price (US$/Unit) by Type (2026-2031)

Table 60. Global PD-1 and PD-L1 Monoclonal Antibody Sales (Units) by Application (2020-2025)

Table 61. Global PD-1 and PD-L1 Monoclonal Antibody Sales (Units) by Application (2026-2031)

Table 62. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Application (2020-2025)

Table 63. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Application (2026-2031)

Table 64. Global PD-1 and PD-L1 Monoclonal Antibody Revenue (US$ Million) by Application (2020-2025)

Table 65. Global PD-1 and PD-L1 Monoclonal Antibody Revenue (US$ Million) by Application (2026-2031)

Table 66. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Application (2020-2025)

Table 67. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Application (2026-2031)

Table 68. Global PD-1 and PD-L1 Monoclonal Antibody Price (US$/Unit) by Application (2020-2025)

Table 69. Global PD-1 and PD-L1 Monoclonal Antibody Price (US$/Unit) by Application (2026-2031)

Table 70. Merk Company Information

Table 71. Merk Description and Business Overview

Table 72. Merk PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Merk PD-1 and PD-L1 Monoclonal Antibody Product

Table 74. Merk Recent Developments/Updates

Table 75. Bristol-Myers Squibb Company Company Information

Table 76. Bristol-Myers Squibb Company Description and Business Overview

Table 77. Bristol-Myers Squibb Company PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Bristol-Myers Squibb Company PD-1 and PD-L1 Monoclonal Antibody Product

Table 79. Bristol-Myers Squibb Company Recent Developments/Updates

Table 80. Roche Company Information

Table 81. Roche Description and Business Overview

Table 82. Roche PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Roche PD-1 and PD-L1 Monoclonal Antibody Product

Table 84. Roche Recent Developments/Updates

Table 85. Pfizer Company Information

Table 86. Pfizer Description and Business Overview

Table 87. Pfizer PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Pfizer PD-1 and PD-L1 Monoclonal Antibody Product

Table 89. Pfizer Recent Developments/Updates

Table 90. AstraZeneca Company Information

Table 91. AstraZeneca Description and Business Overview

Table 92. AstraZeneca PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. AstraZeneca PD-1 and PD-L1 Monoclonal Antibody Product

Table 94. AstraZeneca Recent Developments/Updates

Table 95. Junshi Biosciences Company Information

Table 96. Junshi Biosciences Description and Business Overview

Table 97. Junshi Biosciences PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Junshi Biosciences PD-1 and PD-L1 Monoclonal Antibody Product

Table 99. Junshi Biosciences Recent Developments/Updates

Table 100. Innovent Company Information

Table 101. Innovent Description and Business Overview

Table 102. Innovent PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Innovent PD-1 and PD-L1 Monoclonal Antibody Product

Table 104. Innovent Recent Developments/Updates

Table 105. Hengrui Company Information

Table 106. Hengrui Description and Business Overview

Table 107. Hengrui PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Hengrui PD-1 and PD-L1 Monoclonal Antibody Product

Table 109. Hengrui Recent Developments/Updates

Table 110. BeiGene Company Information

Table 111. BeiGene Description and Business Overview

Table 112. BeiGene PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. BeiGene PD-1 and PD-L1 Monoclonal Antibody Product

Table 114. BeiGene Recent Developments/Updates

Table 115. Alphamab Oncology Company Information

Table 116. Alphamab Oncology Description and Business Overview

Table 117. Alphamab Oncology PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. Alphamab Oncology PD-1 and PD-L1 Monoclonal Antibody Product

Table 119. Alphamab Oncology Recent Developments/Updates

Table 120. Cstone Company Information

Table 121. Cstone Description and Business Overview

Table 122. Cstone PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 123. Cstone PD-1 and PD-L1 Monoclonal Antibody Product

Table 124. Cstone Recent Developments/Updates

Table 125. Akeso Company Information

Table 126. Akeso Description and Business Overview

Table 127. Akeso PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 128. Akeso PD-1 and PD-L1 Monoclonal Antibody Product

Table 129. Akeso Recent Developments/Updates

Table 130. Henlius Biotech Company Information

Table 131. Henlius Biotech Description and Business Overview

Table 132. Henlius Biotech PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 133. Henlius Biotech PD-1 and PD-L1 Monoclonal Antibody Product

Table 134. Henlius Biotech Recent Developments/Updates

Table 135. Lepu Biopharma Company Information

Table 136. Lepu Biopharma Description and Business Overview

Table 137. Lepu Biopharma PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 138. Lepu Biopharma PD-1 and PD-L1 Monoclonal Antibody Product

Table 139. Lepu Biopharma Recent Developments/Updates

Table 140. Key Raw Materials Lists

Table 141. Raw Materials Key Suppliers Lists

Table 142. PD-1 and PD-L1 Monoclonal Antibody Distributors List

Table 143. PD-1 and PD-L1 Monoclonal Antibody Customers List

Table 144. PD-1 and PD-L1 Monoclonal Antibody Market Trends

Table 145. PD-1 and PD-L1 Monoclonal Antibody Market Drivers

Table 146. PD-1 and PD-L1 Monoclonal Antibody Market Challenges

Table 147. PD-1 and PD-L1 Monoclonal Antibody Market Restraints

Table 148. Research Programs/Design for This Report

Table 149. Key Data Information from Secondary Sources

Table 150. Key Data Information from Primary Sources

Table 151. Authors List of This Report

List of Figures

Figure 1. Product Picture of PD-1 and PD-L1 Monoclonal Antibody

Figure 2. Global PD-1 and PD-L1 Monoclonal Antibody Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global PD-1 and PD-L1 Monoclonal Antibody Market Share by Type: 2024 & 2031

Figure 4. PD-1 Product Picture

Figure 5. PD-L1 Product Picture

Figure 6. Global PD-1 and PD-L1 Monoclonal Antibody Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global PD-1 and PD-L1 Monoclonal Antibody Market Share by Application: 2024 & 2031

Figure 8. Hospital

Figure 9. Other Medical Institutions

Figure 10. Global PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 11. Global PD-1 and PD-L1 Monoclonal Antibody Market Size (2020-2031) & (US$ Million)

Figure 12. Global PD-1 and PD-L1 Monoclonal Antibody Sales (2020-2031) & (Units)

Figure 13. Global PD-1 and PD-L1 Monoclonal Antibody Average Price (US$/Unit) & (2020-2031)

Figure 14. PD-1 and PD-L1 Monoclonal Antibody Report Years Considered

Figure 15. PD-1 and PD-L1 Monoclonal Antibody Sales Share by Manufacturers in 2024

Figure 16. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Share by Manufacturers in 2024

Figure 17. Global 5 and 10 Largest PD-1 and PD-L1 Monoclonal Antibody Players: Market Share by Revenue in PD-1 and PD-L1 Monoclonal Antibody in 2024

Figure 18. PD-1 and PD-L1 Monoclonal Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 19. Global PD-1 and PD-L1 Monoclonal Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 20. North America PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Country (2020-2031)

Figure 21. North America PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Country (2020-2031)

Figure 22. U.S. PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 23. Canada PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Europe PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Country (2020-2031)

Figure 25. Europe PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Country (2020-2031)

Figure 26. Germany PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. France PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. U.K. PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. Italy PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Russia PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Asia Pacific PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Region (2020-2031)

Figure 32. Asia Pacific PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Region (2020-2031)

Figure 33. China PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Japan PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. South Korea PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. India PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Australia PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Taiwan PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Indonesia PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Thailand PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Malaysia PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Philippines PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Latin America PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Country (2020-2031)

Figure 44. Latin America PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Country (2020-2031)

Figure 45. Mexico PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Brazil PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Argentina PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Middle East and Africa PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Country (2020-2031)

Figure 49. Middle East and Africa PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Country (2020-2031)

Figure 50. Turkey PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. U.A.E PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Global Sales Market Share of PD-1 and PD-L1 Monoclonal Antibody by Type (2020-2031)

Figure 54. Global Revenue Market Share of PD-1 and PD-L1 Monoclonal Antibody by Type (2020-2031)

Figure 55. Global PD-1 and PD-L1 Monoclonal Antibody Price (US$/Unit) by Type (2020-2031)

Figure 56. Global Sales Market Share of PD-1 and PD-L1 Monoclonal Antibody by Application (2020-2031)

Figure 57. Global Revenue Market Share of PD-1 and PD-L1 Monoclonal Antibody by Application (2020-2031)

Figure 58. Global PD-1 and PD-L1 Monoclonal Antibody Price (US$/Unit) by Application (2020-2031)

Figure 59. PD-1 and PD-L1 Monoclonal Antibody Value Chain

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Screen Compound Libraries Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-19F15647

Mon Mar 10 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Bioprocess Automation Software Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-17E12076

Mon Mar 10 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Aptamers Services Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-30T12168

Mon Mar 10 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Pharmaceutical Raw Material Testing Service Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-11T12769

Mon Mar 10 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions